Interleukin-22: immunobiology and pathology, Annu Rev Immunol, vol.33, pp.747-785, 2015. ,
, The Authors, Ltd on behalf of Australian and New Zealand Society for Immunology, 2020.
IL-22-producing neutrophils contribute to antimicrobial defense and restitution of colonic epithelial integrity during colitis, Proc Natl Acad Sci, vol.110, pp.12768-12773, 2013. ,
IL-22 ameliorates renal ischemia-reperfusion injury by targeting proximal tubule epithelium, J Am Socf Nephrol, vol.25, pp.967-977, 2014. ,
Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens, Nat Med, vol.14, pp.282-289, 2008. ,
Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria, Science, vol.336, pp.1321-1325, 2012. ,
Interleukin-22 in kidney injury and regeneration, Am J Physiol Renal Physiol, vol.308, pp.1041-1046, 2015. ,
IL-22 sustains epithelial integrity in progressive kidney remodeling and fibrosis, Physiol Rep, vol.6, p.13817, 2018. ,
Toll-like receptor 4-induced IL-22 accelerates kidney regeneration, J Am Soc Nephrol, vol.25, pp.978-989, 2014. ,
Endogenous IL-22 is dispensable for experimental glomerulonephritis, Am J Physiol Renal Physiol, vol.316, pp.712-722, 2019. ,
Th22 cells form a distinct Th Lineage from Th17 cells in vitro with unique transcriptional properties and Tbet-dependent Th1 plasticity, J Immunol, vol.198, pp.2182-2190, 2017. ,
Group 2 innate lymphoid cells are redundant in experimental renal ischemia-reperfusion injury, Front Immunol, vol.10, p.826, 2019. ,
Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-tosevere atopic dermatitis inadequately controlled by conventional treatments: a randomized, double-blind, phase 2a trial, J Am Acad Dermatol, vol.78, pp.872-881, 2018. ,
Safety, pharmacokinetics, and biomarkers of F-652, a recombinant human interleukin-22 dimer, in healthy subjects, Cell Mol Immunol, vol.16, pp.473-482, 2018. ,